Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Premier Research appoints Etienne Drouet as executive director, Oncology Europe

January 25, 2012 Business Services, Research and Development, Sales and Marketing Etienne Drouet, Premier Research

 Premier Research Group has announced the appointment of Etienne Drouet to the position of executive director, Oncology Europe.In this position, …
Appointment

Gates urges investment in innovations for developing nations

January 25, 2012 Research and Development AIDS, Bill Gates, Global Fund, TB, malaria

Bill Gates has called on global leaders to invest in innovations that are accelerating progress against poverty, or risk a …
News
Lansley picture

Councils given £2.2 billion for public health

January 25, 2012 Research and Development, Sales and Marketing Lansley, NHS, public health outcomes framework

The government’s new vision for public health has come under fire from observers worried that accountability for the strategy remains …
News

MHRA Inspections of CROs

January 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Audits, Wainwright Associates, inspectons

In accordance with the provisions of the new pharmacovigilance legislation, as per Directive 2010/84/EU, EU Competent Authorities may inspect the …
News
Press release

Moving towards milestones: the evolving pharma – biotech relationship

January 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Deals, Susan Aldridge, biotech, pharma

Big pharma is going through the greatest ever wave of patent expiries, while small biotechs are finding it hard to …
Feature

Richard Barker elected to Celgene’s board of directors

January 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing ABPI, Celgene, Richard Barker

Celgene, the biopharma firm specialising in cancer and inflammatory diseases, has elected Richard Barker to its board of directors. Dr …
Appointment

Alnylam cuts workforce by a third

January 23, 2012 Research and Development, Sales and Marketing Alnylam, Novartis, job cuts, rnai

Alnylam will cut 33% of its workforce this year as it looks to focus on developing its own products. The …
News

Contract research news in brief

January 23, 2012 Research and Development CoreLab Partners and Acurian, Quintiles, vivoPharma

Quintiles invests in new biomarket firm and sets up a new office in China, plus updates from vivoPharma, CoreLab Partners …
News

Payment changes of authority’s fees in France

January 20, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates, regulatory affairs

Changes are being made in the way fees are paid for regulatory submissions and procedures in France.  Fees are no …
News
Press release

Novartis’ Signifor recommended in Europe

January 20, 2012 Research and Development, Sales and Marketing CHMP, Cushing's disease, Novartis, Signifor

A European committee has recommended Novartis’ Signifor for the treatment of a rare, debilitating endocrine disorder. The European Committee for …
News
Gilenya image

EMA to review safety of MS drug Gilenya

January 20, 2012 Research and Development, Sales and Marketing CHMP, EMA, Novartis, gilenya

The European Medicines Agency has begun a review into the safety of Novartis’ multiple sclerosis drug Gilenya. This follows concerns …
News

AZ and BMS diabetes drug needs more data

January 20, 2012 Research and Development, Sales and Marketing AstraZeneca, BMS, FDA approvals, diabetes

AstraZeneca and Bristol-Myers Squibb must supply more data on their diabetes treatment dapagliflozin, the FDA says.Currently being developed as monotherapy, …
News

Novartis starts late-stage biosimilar trials for Amgen drugs

January 19, 2012 Research and Development, Sales and Marketing Amgen, Neulasta, Neupogen, Novartis

Novartis has begun Phase III biosimilar trials to copycat two of Amgen’s neutropenia drugs. The studies, which are being undertaken …
News

Chief operating officer appointed to Clinigen’s services division

January 19, 2012 Business Services, Medical Communications, Research and Development, Sales and Marketing Clinigen, Shaun Chilton

Clinigen Group, a global specialty pharma services and products business, has appointed Shaun Chilton as its new chief operating officer …
Appointment
Takeda image

Takeda to cut 2,800 jobs

January 19, 2012 Business Services, Research and Development, Sales and Marketing Nycomed, Takeda, job cuts

Takeda has announced plans to significantly reduce its global headcount over the next four years following its merger with Nycomed. …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026